Since its launch a few months ago, pCure has had steadily increased sales growth and interest. Pharem´s owners have therefore decided to place the brand, and IP, in its own company. The new company is in line with the ongoing strategy to simplify the interaction between different Pharem products. The strategy will open up for partners and investors with a specific interest in pCure.
The aim of the collaboration between the two companies is to extend the existing technology range for treatment of organic micro-pollutants through Pharem´s modern enzyme technology. The joint focus will primarily be towards wastewater treatment plants (WWTP:s) on the Nordic market.
Pharem is specialized in enzymatic treatment of wastewater to remove organic micro-pollutants.
We use our broad biotechnology expertise to develop innovative enzymatic products which provide an effective means of removing organic pollutants in water environments. Our products are specifically developed to meet client needs for simple, effective solutions to tackle serious environmental issues within their operational scope.
Through close, ongoing collaboration with stakeholders, we are constantly working toward meeting customer’s requirements and exceeding expectations by providing safe, innovative, and cost-efficient products to counteract the impact organic pollutants have on the environment.
